Remission & chronicity

Spontaneous remission

Hashimoto's (most common cause) is irreversible in majority; spontaneous recovery in <5%; subclinical hypothyroidism spontaneously normalizes in ~30-40% of cases within 2 years without treatment

Best-intervention remission

T4 monotherapy normalizes TSH in nearly all patients and resolves symptoms in ~60%; up to 40% of T4-treated patients remain symptomatic despite normalized TSH; T4+T3 combination or desiccated thyroid extract (DTE) preferred by ~50% of patients in blinded preference trials

Gap size

Moderate — within the treated population, a large minority are inadequately treated by the standard-of-care T4 monotherapy approach

Primary barrier

framing/practice

Up to 40% of patients remain symptomatic on T4 despite guideline-defined adequate treatment; T3 combination and DTE are rarely offered in primary care despite guideline acknowledgment that a trial may be appropriate; TSH-only monitoring misses tissue-level hypothyroidism

Biomarker Targets & Therapeutic Agents

Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: ● Clinical > ● Mechanistic > ● Correlative.

CTLA4 32 DIO1 1 DIO2 0 TG 31 THRA 146 THRB 253 TPO 55 TSHR 294

CTLA4

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
TREMELIMUMAB	↓ inhibits	Mechanistic		DGIdb
IPILIMUMAB	↓ inhibits	Mechanistic		DGIdb
CYCLOSPORINE	? unclear	Mechanistic		DGIdb
ATEZOLIZUMAB	? unclear	Mechanistic		DGIdb
VISILIZUMAB	? unclear	Mechanistic		DGIdb
BLEOMYCIN	? unclear	Mechanistic		DGIdb
ANTIBIOTIC	? unclear	Mechanistic		DGIdb
METHIMAZOLE	? unclear	Mechanistic		DGIdb
RETRO-INVERSO PEPTIDE	? unclear	Mechanistic		DGIdb
MELPHALAN	? unclear	Mechanistic		DGIdb
RECOMBINANT FAS LIGAND	? unclear	Mechanistic		DGIdb
ZALIFRELIMAB	↓ inhibits	Mechanistic		DGIdb
RIBAVIRIN	? unclear	Mechanistic		DGIdb
ANTI-THYMOCYTE GLOBULIN	? unclear	Mechanistic		DGIdb
QUAVONLIMAB	↓ inhibits	Mechanistic		DGIdb
COMPOUND 32 [PMID: 20471253]	↓ inhibits	Mechanistic		DGIdb
SIROLIMUS	? unclear	Mechanistic		DGIdb
BISPECIFIC ANTIBODY	? unclear	Mechanistic		DGIdb
CADONILIMAB	↓ inhibits	Mechanistic		DGIdb
APLITHIANINE A	↓ inhibits	Mechanistic		DGIdb
PEGINTERFERON ALFA-2A	? unclear	Mechanistic		DGIdb
INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE INHIBITOR FF-10501-01	? unclear	Mechanistic		DGIdb
ABATACEPT	? unclear	Mechanistic		DGIdb
WORTMANNIN	? unclear	Mechanistic		DGIdb
ERFONRILIMAB	↓ inhibits	Mechanistic		DGIdb
THALIDOMIDE	? unclear	Mechanistic		DGIdb
FF-10501-01	? unclear	Mechanistic		DGIdb
PEGINTERFERON ALFA-2B	? unclear	Mechanistic		DGIdb
TETRADECANOYLPHORBOL ACETATE	? unclear	Mechanistic		DGIdb
DEHYDRATED ALCOHOL	? unclear	Mechanistic		DGIdb
PREDNISONE	? unclear	Mechanistic		DGIdb
CHEMBL5291170	↓ inhibits	Mechanistic	31000.0 nM (Kd)	ChEMBL

DIO1

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
PROPYLTHIOURACIL	↓ inhibits	Mechanistic		DGIdb

DIO2

UniProt Ensembl DGIdb Open Targets

Pipeline results not yet available for this target. Run the pipeline to populate.

TG

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Source
GENISTEIN	? unclear	Mechanistic	DGIdb
VITAMIN A	? unclear	Mechanistic	DGIdb
RECOMBINANT TRANSFORMING GROWTH FACTOR-BETA 1	? unclear	Mechanistic	DGIdb
DEXAMETHASONE	? unclear	Mechanistic	DGIdb
ACEBUTOLOL	? unclear	Mechanistic	DGIdb
AZACITIDINE	? unclear	Mechanistic	DGIdb
VACCINE	? unclear	Mechanistic	DGIdb
AMINOGLYCOSIDE ANTIBIOTIC	? unclear	Mechanistic	DGIdb
FLUORODEOXYGLUCOSE F18	? unclear	Mechanistic	DGIdb
CALCITRIOL	? unclear	Mechanistic	DGIdb
PREDNISONE	? unclear	Mechanistic	DGIdb
HEXAMETHYLENEBISACETAMIDE	? unclear	Mechanistic	DGIdb
PREDNISOLONE	? unclear	Mechanistic	DGIdb
ALDESLEUKIN	? unclear	Mechanistic	DGIdb
PEGINTERFERON ALFA-2A	? unclear	Mechanistic	DGIdb
OCTREOTIDE ACETATE	? unclear	Mechanistic	DGIdb
DEHYDRATED ALCOHOL	? unclear	Mechanistic	DGIdb
ISOTRETINOIN	? unclear	Mechanistic	DGIdb
RETINOIC ACID AGENT	? unclear	Mechanistic	DGIdb
GAMMA-INTERFERON	? unclear	Mechanistic	DGIdb
PHENYTOIN SODIUM	? unclear	Mechanistic	DGIdb
AMIODARONE HYDROCHLORIDE	? unclear	Mechanistic	DGIdb
HEXAMETHYLENE BISACETAMIDE	? unclear	Mechanistic	DGIdb
POLYETHYLENE GLYCOL 4000	? unclear	Mechanistic	DGIdb
ROSIGLITAZONE	? unclear	Mechanistic	DGIdb
TECHNETIUM TC 99M SESTAMIBI	? unclear	Mechanistic	DGIdb
BISPECIFIC ANTIBODY	? unclear	Mechanistic	DGIdb
AMINOGLUTETHIMIDE	? unclear	Mechanistic	DGIdb
ANTIDEPRESSANT AGENT	? unclear	Mechanistic	DGIdb
ADENOVIRUS VECTOR	? unclear	Mechanistic	DGIdb
TRETINOIN	? unclear	Mechanistic	DGIdb

THRA

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
ASPIRIN	? unclear	Mechanistic		DGIdb
LIOTHYRONINE	↑ activates	Mechanistic	0.1 nM (Kd)	DGIdb
LEVOTHYROXINE	↑ activates	Mechanistic		DGIdb
LIOTHYRONINE SODIUM	↑ activates	Mechanistic		DGIdb
TIRATRICOL	? unclear	Mechanistic	0.14 nM (IC50)	DGIdb
DEXTROTHYROXINE	↑ activates	Mechanistic		DGIdb
DEXTROTHYROXINE SODIUM	↑ activates	Mechanistic		DGIdb
LEVOTHYROXINE SODIUM	? unclear	Mechanistic		Open Targets
CHEMBL111953	↓ inhibits	Mechanistic	490.0 nM (Kd)	ChEMBL
CHEMBL109430	↓ inhibits	Mechanistic	5.2 nM (Kd)	ChEMBL
CHEMBL109279	↓ inhibits	Mechanistic	93.0 nM (Kd)	ChEMBL
CHEMBL110158	↓ inhibits	Mechanistic	330.0 nM (Kd)	ChEMBL
SOBETIROME	↓ inhibits	Mechanistic	1.8 nM (Kd)	ChEMBL
CHEMBL112087	↓ inhibits	Mechanistic	200.0 nM (Kd)	ChEMBL
CHEMBL83953	↓ inhibits	Mechanistic	39000.0 nM (IC50)	ChEMBL
CHEMBL86271	↓ inhibits	Mechanistic	1800.0 nM (IC50)	ChEMBL
CHEMBL82131	↓ inhibits	Mechanistic	18100.0 nM (IC50)	ChEMBL
CHEMBL85322	↓ inhibits	Mechanistic	69000.0 nM (IC50)	ChEMBL
CHEMBL83829	↓ inhibits	Mechanistic	930.0 nM (IC50)	ChEMBL
CHEMBL97187	↓ inhibits	Mechanistic	1400.0 nM (Kd)	ChEMBL
CHEMBL318132	↓ inhibits	Mechanistic	112.0 nM (Kd)	ChEMBL
CHEMBL97613	↓ inhibits	Mechanistic	430.0 nM (Kd)	ChEMBL
CHEMBL98135	↓ inhibits	Mechanistic	1400.0 nM (Kd)	ChEMBL
CHEMBL264527	↓ inhibits	Mechanistic	240.0 nM (Kd)	ChEMBL
CHEMBL160883	↓ inhibits	Mechanistic	820.0 nM (IC50)	ChEMBL
CHEMBL160703	↓ inhibits	Mechanistic	1400.0 nM (IC50)	ChEMBL
AMIODARONE	↓ inhibits	Mechanistic	650.0 nM (IC50)	ChEMBL
CHEMBL157885	↓ inhibits	Mechanistic	4500.0 nM (IC50)	ChEMBL
DETROTHYRONINE	↓ inhibits	Mechanistic	0.24 nM (IC50)	ChEMBL
CHEMBL39174	↓ inhibits	Mechanistic	1.4 nM (IC50)	ChEMBL
THYROPROPIC ACID	↓ inhibits	Mechanistic	0.041 nM (IC50)	ChEMBL
CHEMBL40738	↓ inhibits	Mechanistic	130.0 nM (IC50)	ChEMBL
CHEMBL289965	↓ inhibits	Mechanistic	9.7 nM (IC50)	ChEMBL
CHEMBL41036	↓ inhibits	Mechanistic	25.0 nM (IC50)	ChEMBL
CHEMBL289343	↓ inhibits	Mechanistic	0.1 nM (IC50)	ChEMBL
CHEMBL418432	↓ inhibits	Mechanistic	0.76 nM (IC50)	ChEMBL
CHEMBL41314	↓ inhibits	Mechanistic	0.14 nM (IC50)	ChEMBL
CHEMBL125946	↑ activates	Mechanistic	1500.0 nM (EC50)	ChEMBL
CHEMBL124205	↑ activates	Mechanistic	12.0 nM (EC50)	ChEMBL
CHEMBL419016	↓ inhibits	Mechanistic	2.4 nM (Kd)	ChEMBL

Showing top 40 of 146 agents ranked by evidence tier.

THRB

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
METHYL PARATHIONE	? unclear	Mechanistic		DGIdb
DIENOCHLOR	? unclear	Mechanistic		DGIdb
AXITIROME	? unclear	Mechanistic		DGIdb
3-METHYLCHOLANTHRENE	? unclear	Mechanistic		DGIdb
CHEMBL:CHEMBL577415	? unclear	Mechanistic		DGIdb
DYCLONINE HYDROCHLORIDE	? unclear	Mechanistic		DGIdb
LEVOTHYROXINE	↑ activates	Mechanistic		DGIdb
ORTHO-PHTHALALDEHYDE	? unclear	Mechanistic		DGIdb
QUINALIZARIN	? unclear	Mechanistic		DGIdb
CHEMBL:CHEMBL297304	? unclear	Mechanistic		DGIdb
CHEMBL:CHEMBL1493528	? unclear	Mechanistic		DGIdb
RESMETIROM	↑ activates	Mechanistic		DGIdb
CLOSANTEL	? unclear	Mechanistic		DGIdb
IDARUBICIN	? unclear	Mechanistic		DGIdb
FUMARPROTOCETRARIC ACID	? unclear	Mechanistic		DGIdb
DIPYRIDAMOLE	? unclear	Mechanistic		DGIdb
CHEMBL:CHEMBL1341830	? unclear	Mechanistic		DGIdb
CARUBICIN	? unclear	Mechanistic		DGIdb
ALBUTEROL SULFATE	? unclear	Mechanistic		DGIdb
PRIMAQUINE	? unclear	Mechanistic		DGIdb
DEXTROTHYROXINE SODIUM	↑ activates	Mechanistic		DGIdb
SOBETIROME	↑ activates	Mechanistic	0.1 nM (Kd)	DGIdb
METHYLENE BLUE ANHYDROUS	? unclear	Mechanistic		DGIdb
HEXACHLOROPHENE	? unclear	Mechanistic		DGIdb
CHEMBL:CHEMBL1465049	? unclear	Mechanistic		DGIdb
COMPOUND 16G [PMID: 35507418]	↑ activates	Mechanistic		DGIdb
CHLOROTHALONIL	? unclear	Mechanistic		DGIdb
SLAZINIC ACID	? unclear	Mechanistic		DGIdb
TRIAMTERENE	? unclear	Mechanistic		DGIdb
CHEMBL:CHEMBL601952	? unclear	Mechanistic		DGIdb
CHEMBL:CHEMBL578741	? unclear	Mechanistic		DGIdb
CIRAZOLINE	? unclear	Mechanistic		DGIdb
CHEMBL:CHEMBL581044	? unclear	Mechanistic		DGIdb
DAUNORUBICIN HYDROCHLORIDE	? unclear	Mechanistic		DGIdb
RT3	↑ activates	Mechanistic		DGIdb
CHEMBL:CHEMBL592124	? unclear	Mechanistic		DGIdb
VK-2809	↑ activates	Mechanistic		DGIdb
CHEMBL:CHEMBL602969	? unclear	Mechanistic		DGIdb
EPROTIROME	↑ activates	Mechanistic		DGIdb
TOLONIUM CHLORIDE	? unclear	Mechanistic		DGIdb

Showing top 40 of 253 agents ranked by evidence tier.

TPO

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
CARBIMAZOLE	↓ inhibits	Mechanistic		DGIdb
PROPYLTHIOURACIL	↓ inhibits	Mechanistic	3380.0 nM (IC50)	DGIdb
TRETINOIN	? unclear	Mechanistic		DGIdb
METHIMAZOLE	↓ inhibits	Mechanistic		DGIdb
CHEMBL4278946	↓ inhibits	Mechanistic	3900.0 nM (IC50)	ChEMBL
CHEMBL4282403	↓ inhibits	Mechanistic	6000.0 nM (IC50)	ChEMBL
CHEMBL4482878	↓ inhibits	Mechanistic	4000.0 nM (IC50)	ChEMBL
CHEMBL333928	↓ inhibits	Mechanistic	42000.0 nM (IC50)	ChEMBL
CHEMBL4637728	↓ inhibits	Mechanistic	30000.0 nM (IC50)	ChEMBL
CHEMBL4645343	↓ inhibits	Mechanistic	5300.0 nM (IC50)	ChEMBL
CHEMBL4633000	↓ inhibits	Mechanistic	5900.0 nM (IC50)	ChEMBL
CHEMBL4753981	↓ inhibits	Mechanistic	2200.0 nM (IC50)	ChEMBL
CHEMBL4792720	↓ inhibits	Mechanistic	6300.0 nM (IC50)	ChEMBL
CHEMBL4751166	↓ inhibits	Mechanistic	59000.0 nM (IC50)	ChEMBL
CHEMBL4755252	↓ inhibits	Mechanistic	12300.0 nM (IC50)	ChEMBL
CHEMBL4869433	↓ inhibits	Mechanistic	700.0 nM (IC50)	ChEMBL
CHEMBL4859908	↓ inhibits	Mechanistic	640.0 nM (IC50)	ChEMBL
CHEMBL4855030	↓ inhibits	Mechanistic	2000.0 nM (IC50)	ChEMBL
CHEMBL4855931	↓ inhibits	Mechanistic	710.0 nM (IC50)	ChEMBL
CHEMBL4846080	↓ inhibits	Mechanistic	2300.0 nM (IC50)	ChEMBL
CHEMBL4853722	↓ inhibits	Mechanistic	1100.0 nM (IC50)	ChEMBL
CHEMBL4863015	↓ inhibits	Mechanistic	1100.0 nM (IC50)	ChEMBL
CHEMBL4871587	↓ inhibits	Mechanistic	1800.0 nM (IC50)	ChEMBL
CHEMBL4855956	↓ inhibits	Mechanistic	6700.0 nM (IC50)	ChEMBL
CHEMBL4878518	↓ inhibits	Mechanistic	1900.0 nM (IC50)	ChEMBL
CHEMBL4862053	↓ inhibits	Mechanistic	1100.0 nM (IC50)	ChEMBL
CHEMBL4860429	↓ inhibits	Mechanistic	1700.0 nM (IC50)	ChEMBL
CHEMBL4877407	↓ inhibits	Mechanistic	14000.0 nM (IC50)	ChEMBL
CHEMBL4859470	↓ inhibits	Mechanistic	21000.0 nM (IC50)	ChEMBL
PF-06282999	↓ inhibits	Mechanistic	990.0 nM (IC50)	ChEMBL
CHEMBL5200638	↓ inhibits	Mechanistic	590.0 nM (IC50)	ChEMBL
CHEMBL5181827	↓ inhibits	Mechanistic	4200.0 nM (IC50)	ChEMBL
CHEMBL5182747	↓ inhibits	Mechanistic	8100.0 nM (IC50)	ChEMBL
CHEMBL5185576	↓ inhibits	Mechanistic	1500.0 nM (IC50)	ChEMBL
CHEMBL5172456	↓ inhibits	Mechanistic	1300.0 nM (IC50)	ChEMBL
CHEMBL5197968	↓ inhibits	Mechanistic	1390.0 nM (IC50)	ChEMBL
CHEMBL5197383	↓ inhibits	Mechanistic	3400.0 nM (IC50)	ChEMBL
CHEMBL5175091	↓ inhibits	Mechanistic	1400.0 nM (IC50)	ChEMBL
CHEMBL5207346	↓ inhibits	Mechanistic	4200.0 nM (IC50)	ChEMBL
CHEMBL5186129	↓ inhibits	Mechanistic	1900.0 nM (IC50)	ChEMBL

Showing top 40 of 55 agents ranked by evidence tier.

TSHR

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Source
PENTACHLOROPHENOL	? unclear	Mechanistic	DGIdb
THYROTROPIN ALFA	↑ activates	Mechanistic	DGIdb
CILOSTAZOL	? unclear	Mechanistic	DGIdb
ALPHA-NAPHTHOFLAVONE	? unclear	Mechanistic	DGIdb
GRAMINE	? unclear	Mechanistic	DGIdb
TESTOSTERONE PROPIONATE	? unclear	Mechanistic	DGIdb
SB 222200	? unclear	Mechanistic	DGIdb
URAPIDIL	? unclear	Mechanistic	DGIdb
CHEMBL:CHEMBL312032	? unclear	Mechanistic	DGIdb
CHEMBL:CHEMBL578276	? unclear	Mechanistic	DGIdb
CHEMBL:CHEMBL606166	? unclear	Mechanistic	DGIdb
AM-630	? unclear	Mechanistic	DGIdb
CHEMBL:CHEMBL607309	? unclear	Mechanistic	DGIdb
LEVALBUTEROL	? unclear	Mechanistic	DGIdb
CHEMBL:CHEMBL140220	? unclear	Mechanistic	DGIdb
ICI-199441	? unclear	Mechanistic	DGIdb
LASALOCID A SODIUM	? unclear	Mechanistic	DGIdb
CLOSANTEL	? unclear	Mechanistic	DGIdb
DIPYRIDAMOLE	? unclear	Mechanistic	DGIdb
ANTISERUM	? unclear	Mechanistic	DGIdb
ISOPROTERENOL	? unclear	Mechanistic	DGIdb
SEROTONIN	? unclear	Mechanistic	DGIdb
NMDA	? unclear	Mechanistic	DGIdb
BERGAMOTTIN	? unclear	Mechanistic	DGIdb
3,6-DIMETHOXYFLAVONE	? unclear	Mechanistic	DGIdb
L-733,060	? unclear	Mechanistic	DGIdb
TYRPHOSTIN AG 879	? unclear	Mechanistic	DGIdb
CARBONYL CYANIDE M-CHLOROPHENYLHYDRAZONE	? unclear	Mechanistic	DGIdb
CP-339818	? unclear	Mechanistic	DGIdb
DICHLOROPHEN	? unclear	Mechanistic	DGIdb
CLORGILINE	? unclear	Mechanistic	DGIdb
DEXPROPRANOLOL	? unclear	Mechanistic	DGIdb
TYRPHOSTIN A9	? unclear	Mechanistic	DGIdb
CHEMBL:CHEMBL429095	? unclear	Mechanistic	DGIdb
CLIOXANIDE	? unclear	Mechanistic	DGIdb
PIPERONYL BUTOXIDE	? unclear	Mechanistic	DGIdb
CHEMBL:CHEMBL1456848	? unclear	Mechanistic	DGIdb
KARANJIN	? unclear	Mechanistic	DGIdb
THYROTROPIN	↑ activates	Mechanistic	DGIdb
KINETIN	? unclear	Mechanistic	DGIdb

Showing top 40 of 294 agents ranked by evidence tier.

Clinical Trials

Recruiting and recently completed trials from ClinicalTrials.gov. Data retrieved 2026-07-06.

No recent clinical trials found on ClinicalTrials.gov for this condition.

Agents Found By Disease-Level Search

Searched directly from “Hypothyroidism” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 8-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).

40 agents shown (approved or with trial evidence) — 35 not found by the gene-target search above.

Levothyroxine

Approved · 11 trials · source: ClinicalTrials.gov, Open Targets
NCT04124705 NCT05412979 NCT01950260

levothyroxine sodium

Approved · 3 trials · source: ClinicalTrials.gov, Open Targets
NCT05823012 NCT00921050 NCT03880578

L-carnitineNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01769157

Armour® ThyroidNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT04124705

ST-1891NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT05412979

Quality of life assessment, biochemical measuresNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT05015725

MNP groupNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02280330

Quantitative POC TSH KitNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01921452

Qualitative POC TSH KitNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01921452

Third generation TSH KitNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01921452

Liothyronine, Sodium

Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01800617

LT3 (liothyronine)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT05682482

Mini gastric bypass surgeryNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06015620

fatigue assessment and managementNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00336102

management of therapy complicationsNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00336102

Eltroxin administrationNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06154382

ThyroxineNOT in gene-target list

Unknown · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT05385029

Serum thyroid function testsNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT04860622

excipient without levothyroxine (placebo)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00921050

TRH (Thyrotropin Releasing Hormone)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00054756

Assesment of thyroïd functionNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT04831957

Liothyronine

Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT04782856

Thyroid function testNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT05033496

D-THIO (Deprescribing Thyroid Hormone In Older Adults)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06629272

Enhanced usual careNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06629272

L-thyroxineNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00524238

Clinical Pharmacist Intervention GroupNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06408909

Thyroid Function MonitoringNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT07048548

Levothyroxine/Liothyronine once dailyNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06731764

Levothyroxine/Liothyronine twice dailyNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT06731764

Levothyroxine sodium new formulationNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01916304

Brand Name Levothyroxine (Synthroid)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00403390

Generic formulation of LevothyroxineNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00403390